Middle East Healthcare Co. (Saudi German Health) Announces the Completion of Issuing Sukuk Denominated in SAR

26 February 2024
Introduction
Introduction

With reference to the announcement made by the Middle East Healthcare Company (the “Company”) published on the website of the Saudi Stock Exchange (Tadawul) on 02/08/1445H (corresponding to 12/02/2024G) relating to the commencement of the Company’s offer and subscription in its Sukuk denominated in SAR (the “Sukuk”) by way of a public offer, the Company announces that it has completed the offer and subscription of the Sukuk.
Offer Type

Sukuk denominated in SAR
Value of the offer

SAR 1,000,000,000
Total number of (Bonds/Sukuk)

1,000,000 Sak
Par Value (Bonds/Sukuk)

SAR 1,000 per Sak.
Return (Bonds/Sukuk)

7.20% per annum fixed rate payable quarterly
Maturity (Bonds/Sukuk)

5 years
Terms of Redemption

The Company may redeem the Sukuk, in certain events, before the expiry date as detailed in the Base Prospectus and the applicable final terms
Additional Information

Investors can review the applicable final terms for this series of Sukuk to be published on Al Rajhi Capital Company’s website (in its capacity as lead manager) on 6 March 2024.

The allocation of the Sukuk to the investors will complete by the end of Thursday 19/08/1445H (corresponding to 29/02/2024G) and the settlement of the Sukuk will take place on 25/08/1445H (corresponding to 06/03/2024G).

The process of refunding the excess subscription monies to the eligible investors will start on 25/08/1445H, (corresponding to 06/03/2024G), and the excess subscription monies will be deposited in the accounts of the eligible investors in accordance with the procedures adopted by the relevant entities.

After the completion of all regulatory procedures required for the listing of the Sukuk, the Sukuk will be listed and trading on the Saudi Exchange (Tadawul) will commence, and an announcement will be made at that time.

This announcement is not intended as an invitation or offer to purchase, acquire or subscribe to any securities and is subject to the terms and conditions of the Sukuk. The Company will announce any other relevant material developments in due course as required by the relevant rules and regulations.